Year: 2018
Type: review
Abstract: Current data indicate that the "bronchiolitis" diagnosis comprises more than one condition. Clinically, pathophysiologically, and even genetically three main clusters of patients can be identified among children suffering from severe bronchiolitis (or first wheezing episode): (a) respiratory syncytial virus (RSV)-induced bronchiolitis, characterized by young age of the patient, mechanical obstruction of the airways due to mucus and cell debris, and increased risk of recurrent wheezing. For this illness, an effective prophylactic RSV-specific monoclonal antibody is available; (b) rhinovirus-induced wheezing, associated with atopic predisposition of the patient and high risk of subsequent asthma development, which may, however, be reversed with systemic corticosteroids in those with severe illness; and (c) wheeze due to other viruses, characteristically likely to be less frequent and severe. Clinically, it is important to distinguish between these partially overlapping patient groups as they are likely to respond to different treatments. It appears that the first episode of severe bronchiolitis in under 2-year-old children is a critical event and an important opportunity for designing secondary prevention strategies for asthma. As data have shown bronchiolitis cannot simply be diagnosed using a certain cutoff age, but instead, as we suggest, using the viral etiology as the differentiating factor.
Source: Allergy
DOI: 10.1111/all.13624
Authors: Tuomas Jartti, Hermelijn H. Smits, Klaus Bønnelykke, Ozlem Bircan, Varpu Elenius, Jon R. Konradsen, Paraskevi Maggina, Heidi Makrinioti, Jakob Stokholm, Gunilla Hedlin, Nikolaos Papadopoulos, Marek Ruszczynski, Klaudia Ryczaj, Bianca Schaub, Jürgen Schwarze, Chrysanthi Skevaki, Katarina Stenberg‐Hammar, Wojciech Feleszko
Institutions: University of Turku, Turku University Hospital, Leiden University Medical Center, University of Copenhagen, Gentofte Hospital, Copenhagen Prospective Studies on Asthma in Childhood, Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi, Istanbul Medeniyet University, Karolinska University Hospital, Karolinska Institutet, National and Kapodistrian University of Athens, Imperial College Healthcare NHS Trust, University of Manchester, Medical University of Warsaw, German Center for Lung Research, Ludwig-Maximilians-Universität München, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Philipps University of Marburg, Universities of Giessen and Marburg Lung Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,300
OpenAlex ID: W2895086809
